跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TIOSPIREX 13 mcg inhalation powder, hard capsule - HSA Drug Approval Details
Approvals
/
HSA
/
TIOSPIREX 13 mcg inhalation powder, hard capsule
Approved
THERAPEUTIC
TIOSPIREX 13 mcg inhalation powder, hard capsule
Laboratorios Liconsa, S.A.
🇸🇬 Health Sciences Authority
Approval Date
Nov 19, 2019
Approval ID
cf6a63bf5f285050
Company
Laboratorios Liconsa, S.A.
Type
Therapeutic
Approval Details
Approval Id
cf6a63bf5f285050
Drug Name
TIOSPIREX 13 mcg inhalation powder, hard capsule
Product Name
TIOSPIREX 13 mcg inhalation powder, hard capsule
Approval Number
SIN15858P
Approval Date
2019-11-19
Registrant
DKSH SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
CAPSULE
Route Of Administration
RESPIRATORY (INHALATION)
Atc Code
R03BB04
Atc Item Name
tiotropium bromide
Pharma Manufacturer Name
DKSH SINGAPORE PTE. LTD.
Company Detail Path
/organization/dksh-singapore-pte-ltd
Active Ingredients
TIOTROPIUM BROMIDE 0.0156 mg EQV TIOTROPIUM
0.013mg
TIOTROPIUM BROMIDE 0.0156 mg EQV TIOTROPIUM
0.013mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 19, 2019
Approval ID
cf6a63bf5f285050
Type
Therapeutic
Back to HSA Approvals
